Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on June 8, 2026

Jun. 8, 2026

NoOnes Pushes Virtual Cards as a Bridge Between Crypto and the Global Financial System

Indeterminate EIN Presswire

Jun. 8, 2026

Gareth Witten Hits Amazon Best-Seller Status with 'Lead with Empathy' Book Co-Authored with Chris Voss

Indeterminate EIN Presswire

Jun. 8, 2026

DANNY DILIBERTO OF LADLES OF LOVE JOINS NEVER GIVE UP DAY AS AMBASSADOR, LEADING GLOBAL WALK FOR NO CHILD TO GO HUNGRY

Indeterminate EIN Presswire

Jun. 8, 2026

Japanische Unternehmerin aus München erreicht über 30.000 Menschen

Indeterminate EIN Presswire

Jun. 8, 2026

Latin America, Africa & Asia-Pacific Data Center Market Size to Reach $530.62 Billion by 2033 | CAGR 15.4%

Indeterminate EIN Presswire

Jun. 8, 2026

New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

Tango Therapeutics Announces Proposed $500 Million Public Offering

Indeterminate GlobeNewswire

Jun. 8, 2026

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 8, 2026

XS.com Conclui a Turnê LATAM com Sucesso em Evento Privado para Clientes e Parceiros

Indeterminate EIN Presswire

Jun. 8, 2026

High-Grade Antimony Assays from Trenching on the South Zone on the Bald Hill Property Under Option from Globex

Indeterminate GlobeNewswire

Jun. 8, 2026

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Indeterminate GlobeNewswire

Jun. 8, 2026

Anortech Enters Carbon Capture Research Collaboration with the National Research Council of Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire

Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

Indeterminate GlobeNewswire

Jun. 8, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Indeterminate GlobeNewswire

Jun. 8, 2026

Hexiris Ophthalmics Marks Scientific Milestones, Launches Digital Presence, and Announces Hands-On Dry Lab at COS Annual Meeting, Montreal

Indeterminate GlobeNewswire

Jun. 8, 2026

Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote

Indeterminate GlobeNewswire